ImmunoPrecise Antibodies Ltd.
Hedge Funds Holdings
Last updated:
ImmunoPrecise Antibodies Ltd.‘s stocks are currently a part of 7 hedge funds’ portfolios, which represents 5.9% of the total amount of its stocks outstanding. This makes up a total of 1.16M shares of ImmunoPrecise Antibodies Ltd.. Compared to the previous quarter, the number fell by -18.52% or -264.06K shares fewer. As for the holding position changes, 42.86% (3) of current hedge fund investors increased the number of shares held, 28.57% (2) of current holders sold a part of the shares held, and 57.14% (4) closed the holdings completely.
Hedge funds holding ImmunoPrecise Antibodies Ltd. (Q4 2020 – Q1 2023)
| Q4 2020 | 13 |
|---|---|
| Q1 2021 | 18 |
| Q2 2021 | 20 |
| Q3 2021 | 23 |
| Q4 2021 | 18 |
| Q1 2022 | 15 |
| Q2 2022 | 17 |
| Q3 2022 | 16 |
| Q4 2022 | 17 |
| Q1 2023 | 7 |
Hedge funds changes in ImmunoPrecise Antibodies Ltd. positions (Q4 2020 – Q1 2023)
| Q4 2020 | 13 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2021 | 8 | 8 | 1 | 3 | -2 |
| Q2 2021 | 4 | 7 | 5 | 2 | 2 |
| Q3 2021 | 11 | 8 | 3 | 8 | -7 |
| Q4 2021 | 1 | 7 | 8 | 5 | -3 |
| Q1 2022 | 3 | 4 | 4 | 6 | -2 |
| Q2 2022 | 4 | 3 | 5 | 2 | 3 |
| Q3 2022 | 3 | 6 | 2 | 4 | 1 |
| Q4 2022 | 4 | 5 | 3 | 3 | 2 |
| Q1 2023 | 0 | 3 | 2 | 4 | -2 |
Hedge funds changes in ImmunoPrecise Antibodies Ltd. stock options (Q4 2020 – Q1 2023)
| Q4 2020 | 0 | 0 |
|---|---|---|
| Q1 2021 | 0 | 0 |
| Q2 2021 | 469,000 | 1,000 |
| Q3 2021 | 2,340,000 | 1,148,000 |
| Q4 2021 | 2,050,000 | 679,000 |
| Q1 2022 | 3,783,000 | 387,000 |
| Q2 2022 | 2,979,000 | 217,000 |
| Q3 2022 | 2,610,000 | 154,000 |
| Q4 2022 | 4,101,733 | 307,884 |
| Q1 2023 | 143,856,000 | 1,411,000 |